Bicara Therapeutics Inc. Share Price & Technical Analysis
BCAX · $20.00 (+1.83%)
Healthcare / Biotechnology
$20.00
+1.83%
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was i…
Price chart
Seasonality
Jun has 0 positive and 2 negative years (last 3 years shown)
-8% return in Jun, -1% avg return in past 3 year Jun month.
24% return in 2026, -4% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -1% | 1% | 23% | 8% | 1% | -8% | – | – | – | – | – | – | 24% |
| 25 | -28% | 10% | -2% | 14% | -37% | -1% | 21% | 9% | 33% | 3% | 16% | -8% | 30% |
| 24 | – | – | – | – | – | – | – | – | -3% | -6% | -14% | -17% | -39% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.30B
P/E ratio
—
52W high
$24.25
52W low
$8.48
Volume
5,48,319
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Bicara Therapeutics Inc. share price today?
- Bicara Therapeutics Inc. (BCAX) last traded around $20.00 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BCAX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BCAX. Download the app for real-time alerts.
- How can I analyze Bicara Therapeutics Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.